Abiopharma

News list

Lyons Michael P. 🟢 acquired 351.9K shares (2 derivative) of TRUIST FINANCIAL CORP (TFC) Transaction Date: Sep 01, 2026 | Filing ID: 000014

Full text

News bot Sept. 3, 2026, 5:57 p.m.
🔍 Lyons Michael P. (Executive)

Company: TRUIST FINANCIAL CORP (TFC)

Report Date: 2026-09-01
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 2
- Holdings reported: 0
- Total shares acquired: 351,941
Detailed Transactions and Holdings:
- Acquired 84,951 shares of Restricted Stock Units (Derivative)
  Date: 2026-09-01 | Code: A | equity_swap_involved: false | shares_owned_after: 84,951.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1
- Acquired 266,990 shares of Restricted Stock Units (Derivative)
  Date: 2026-09-01 | Code: A | equity_swap_involved: false | shares_owned_after: 266,990.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2
Footnotes:
- F1: On September 1, 2026, the reporting person was granted 84,951 restricted stock units, vesting in one-third increments on March 15, 2028, March 15, 2029, and March 15, 2030. Each restricted stock unit represents a right to receive one share of TFC common stock.
- F2: On September 1, 2026, the reporting person was granted 266,990 restricted stock units, vesting in three equal installments on September 1, 2027, September 1, 2028, and September 1, 2029. Each restricted stock unit represents a right to receive one share of TFC common stock.